Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Non-Current Deffered Revenue: 2024

Historic Non-Current Deffered Revenue for Gossamer Bio (GOSS) over the last 1 years, with Dec 2024 value amounting to $38.9 million.

  • Gossamer Bio's Non-Current Deffered Revenue fell 38.13% to $27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.1 million, marking a year-over-year decrease of 38.13%. This contributed to the annual value of $38.9 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Gossamer Bio's Non-Current Deffered Revenue is $38.9 million.
  • Over the past 5 years, Gossamer Bio's Non-Current Deffered Revenue peaked at $38.9 million during FY2024, and registered a low of $38.9 million during FY2024.
  • In the last 1 years, Gossamer Bio's Non-Current Deffered Revenue had a median value of $38.9 million in 2024 and averaged $38.9 million.